Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Karessa Pharma Holding AB (publ)
AB
Dissolved
Org 5569421596
Other research and experimental development on natural sciences and engineering
· NACE 7219
Est. 2013
2 employees
Watchlist
Share
Sweden
/
Companies
/
Other research and experimental development on natural sciences and engineering
/
Karessa Pharma Holding AB (publ)
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (2)
MA
Mats Anders Nilsson
Chief Executive Officer
Chief Executive Officer
2019 – 2020
EN
Eric Niklas Nordström
Chief Auditor
Chief Auditor
2019 – 2020
Board of directors
Non-executive oversight
Name
Role
Member since
Former (5)
AK
Ann Kristina Lidén Mascher
Board of Directors
2019 – 2020
CF
Claes Fredrik Hübinette
Chairman
2019 – 2020
TS
Tord Stefan Erik Arver
Board of Directors
2019 – 2020
NA
Neal Allen Meacham
Board of Directors
2019 – 2020
CS
Charles Scott Boyer
Board of Directors
2019 – 2020
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Karessa Pharma Holding AB (publ)
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network